Adverts

Open Access Articles- Top Results for Lucatumumab

Lucatumumab

</th></tr>
Lucatumumab?
Monoclonal antibody
Type Whole antibody
Source Human
Target CD40
Clinical data
Identifiers
903512-50-5 7pxN
None
UNII P0EP9VFC4R 7pxY
KEGG D08942 7pxY
Chemical data
146 kDa
 14pxN (what is this?)  (verify)

Lucatumumab is a human monoclonal antibody[1] being investigated for the treatment of various types of cancer like multiple myeloma,[2] non-Hodgkin's or Hodgkin's lymphoma.[3]

This drug was developed by Novartis Pharmaceuticals Corp.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council – Lucatumumab, American Medical Association.
  2. ^ Clinical trial number NCT00231166 at ClinicalTrials.gov
  3. ^ Clinical trial number NCT00670592 at ClinicalTrials.gov


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.